CD274 and neoplasm: Shah and colleagues used machine learning to integrate features from computed tomography scan images, programmed death ligand-1 (PD-L1) immunohistochemistry and genomics into a multimodal predictor of response to anti-PD(L)1 in patients with NSCLC that outperformed single features such as tumor mutational burden.